Follow The Filings

CRI Carter's

Carter's earnings company data as of 3:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 26 Oct EPS 0.85 — —
Rev — — —

Insider trades

Open-market buys and sales by CRI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CRI insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 37 stock grants, 28 share withholdings for taxes, 5 sales back to the company, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 8.01,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 5.07,7.01,9.01
8-K 2.02,9.01
10-Q
8-K 2.02,5.02,7.01,9.01
DEFA14A
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.